Literature DB >> 15363997

Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide-treated rats.

Kansu Büyükafşar1, Onur Arikan, Mustafa Ark, Havva Kubat, Elif Ozveren.   

Abstract

Effects of bacterial lipopolysaccharide (Escherichia coli serotype, 055:B5, 20 mg kg(-1), i.p., for 6 h) and a Rho-kinase inhibitor, (+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl) cyclohexanecarboxamide dihydrochloride monohydrate, Y-27632 (10(-9)-10(-5) M) were investigated on the contractile responses of the rat mesenteric artery to phenylephrine (10(-9)-3 x 10(-5) M), angiotensin-2 (10(-10)-10(-6) M) and endothelin-1 (10(-10)-10(-7) M). Moreover, alteration in the level of Rho-kinase (ROCK-2) expression was examined in the superior mesenteric artery obtained from saline- and lipopolysaccharide-treated rats by Western blotting. Endotoxemic rat mesenteric rings exhibited no different contractions to phenylephrine and angiotensin-2 but augmented contractile activity to endothelin-1. In the mesenteric artery obtained from the endotoxemic rats, acetylcholine-induced vasorelaxation did not differ; pD2 value for acetylcholine was 7.85+/-0.12 in the endotoxemic rings; however, it was 7.81+/-0.15 in the control rings (P>0.05). Y-27632 induced relaxation, which was the same in the control arteries as in endotoxemic ones when contracting agent was phenylephrine. However, when endothelin-1 was used to precontract the rings, Y-27632 produced enhanced relaxation in endotoxemic vessels. pD2 values for Y-27632 were, respectively, 7.69+/-0.12 and 8.20+/-0.10 in control and endotoxemic rings precontracted by endothelin-1 (10(-8) M) (P<0.01). Moreover, Y-27632 (10(-5) M) suppressed the contraction induced by angiotensin-2 (10(-10)-10(-6) M). Western blot analysis revealed that Rho-kinase was upregulated significantly in the mesenteric artery obtained from the rats treated with LPS for 6 h. In addition, serum NO2-/NO3- level, which was detected by Griess method, was 10.0+/-1.4 microM in endotoxemic rats; however, it was 6.6+/-0.5 microM in control (P<0.05). Taken together, these results show that the expression of the contractile protein Rho-kinase could be upregulated in endotoxemic mesenteric artery and this upregulation may be coincided with an enhanced contraction to endothelin-1 but not phenylephrine and angiotensin-2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363997     DOI: 10.1016/j.ejphar.2004.07.092

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Rho kinase (ROCK) inhibitors.

Authors:  James K Liao; Minoru Seto; Kensuke Noma
Journal:  J Cardiovasc Pharmacol       Date:  2007-07       Impact factor: 3.105

2.  Induction of endothelium-dependent constriction of mesenteric arteries in endotoxemic hypotensive shock.

Authors:  Tzu-Ling Tseng; Mei-Fang Chen; Chin-Hung Liu; Cheng-Yoong Pang; Yung-Hsiang Hsu; Tony J F Lee
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

Review 3.  Cytoskeletal regulation of epithelial barrier function during inflammation.

Authors:  Andrei I Ivanov; Charles A Parkos; Asma Nusrat
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

Review 4.  Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.

Authors:  Qian Zhou; Christoph Gensch; James K Liao
Journal:  Trends Pharmacol Sci       Date:  2011-01-16       Impact factor: 14.819

Review 5.  Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?

Authors:  James K Liao
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

6.  Effects of the Rho/Rho-Kinase Pathway on Perfusion Pressure in the Isolated-Perfused Rat Hind Limb Vascular Bed.

Authors:  Esra İlhan; Kansu Büyükafşar; R Nalan Tiftik; M Ata Seçilmiş; Zayed Alzayed
Journal:  Balkan Med J       Date:  2021-09       Impact factor: 2.021

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.